STAAR Surgical Issues Shareholder Letter STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today issued a Shareholder Letter on Tuesday, March 3 after the market close. STAAR’ s results release can be found here: https://investors.staar.com/news-and-events/press-releases. This past month marked an important...

#STAA STAAR Surgical Issues Shareholder Letter

www.stocktitan.net/news/STAA/staar-surgical...

STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results Net sales of $57.8 million, up 18.1% Y/Y Net sales excluding China of $40.3 million, down 2.1% Y/Y Gross margin at 75.7% vs. 64.7% Y/Y Net loss of$ million or$ per share, compared to a net loss of$ million or$ per share a year ago Adjusted EBITDA 1 breakeven or$ per share, compared to Adjusted EBITDA loss of$ million or$ per share a year ago. Net sales of $239.4 million, down 23.7%...

#STAA STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results

www.stocktitan.net/news/STAA/staar-surgical...

Bol wint bij debuut op 800 meter direct in Nederlands indoorrecord In Metz komt de koningin van de 400 meter horden tot een tijd van 1.59,07. Daarmee is ze ruim sneller dan de oude toptijd van Ester Goossens uit 2001.

Wow dat is bijzonder, in de 1ste race na haar overstap naar de 800m het 25 jaar oude Nederlands indoorrecord van Esther Goossens verbroken. Esther was destijds #AV34 en #STAA- atlete volgens mij.

nos.nl/artikel/2601...

Small-cap stocks in new downtrend according to average directional index, Wed Jan 7th - #WACD #STAA #PAYS #NEXT #MVBF #BCAB #ANGO #VET #OSG #MBI #GSBD #FBRT #BOW - More: crystalequityresearch.com/leading-indi... - #smallcap

Eye care giant Alcon calls off planned takeover of STAAR Surgical Alcon ends its merger agreement with STAAR Surgical but says its refractive strategy remains unchanged as it rolls out 10+ new eye care products.

#ALC #STAA Alcon Terminates Agreement to Acquire STAAR Surgical

www.stocktitan.net/news/ALC/alcon-terminate...

Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon Broadwood Partners, which owns 30.2% of STAAR common stock (NASDAQ: STAA), thanked shareholders after preliminary results from the January 6, 2026 Special Meeting showed a decisive vote to reject the proposed acquisition of STAAR by Alcon (NYSE: ALC). Broadwood reiterated confidence in STAAR’s standalone prospects, citing leading technology, a strong financial position, large market opportunities, and a path to margin expansion.Broadwood said it is ready to engage with the board and fellow shareholders to implement changes aimed at improving oversight and execution to help STAAR pursue growth and profitability as an independent company.

#ALC #STAA Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon

www.stocktitan.net/news/ALC/broadwood-partn...

STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders STAAR Surgical (NASDAQ: STAA) announced preliminary results from its Special Meeting of Stockholders on January 6, 2026 showing it did not receive the required votes to approve the merger with Alcon. STAAR intends to terminate the merger agreement. No termination fee will be payable by either party. STAAR will remain a standalone, publicly traded company and continue to trade on Nasdaq under the ticker STAA. Final certified results will be filed in a Form 8-K with the SEC.

#STAA STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders

www.stocktitan.net/news/STAA/staar-surgical...

Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon Broadwood Partners, L.P. and its affiliates, which together own 30.2% of the outstanding common stock of STAAR Surgical Company, today responded to the fourth postponement of STAAR’ s Special Meeting of Shareholders in connection with the proposed acquisition of STAAR by Alcon Inc.. The Special Meeting, which was originally scheduled to be held on October 23,...

#ALC #STAA Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon

www.stocktitan.net/news/ALC/broadwood-partn...

Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders STAAR Surgical Company, the manufacturer of the Implantable Collamer ® Lens today announced that Alcon has exercised its right under the Alcon merger agreement to require STAAR to adjourn its Special Meeting of Stockholders in connection with the Alcon merger agreement. As a result, the Special Meeting, which was scheduled for December 19, 2025 at...

#ALC #STAA Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders

www.stocktitan.net/news/ALC/alcon-exercises...

Voormalig #STAA atlete Marije van Hunenstijn stopt met topsport. Bedankt Marije voor veel mooie momenten.

Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails Broadwood Partners, L.P. and its affiliates today issued the following letter to the Board of Directors of STAAR Surgical Company. Broadwood, which owns 30.2% of STAAR’ s outstanding common stock, continues to urge its fellow shareholders to vote“ AGAINST” the proposed acquisition of STAAR by Alcon Inc.. STAAR Surgical Company 25510 Commercentre Dr. Lake Forest,...

#ALC #STAA Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails

www.stocktitan.net/news/ALC/broadwood-partn...

Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory Yunqi Capital Limited, an investment management firm and 5.1% shareholder of STAAR Surgical Company, today released the following letter to STAAR shareholders in response to the updated reports of Institutional Shareholder Services Inc. and Glass, Lewis& Co., LLC regarding the proposed acquisition of STAAR by Alcon Inc.. The text of the letter is as follows:.

#ALC #STAA Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory

www.stocktitan.net/news/ALC/yunqi-capital-c...

Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction STAAR Surgical (NASDAQ:STAA) announced that independent analysts and proxy advisor ISS view the amended Alcon (SIX/NYSE:ALC) merger as providing value to STAAR stockholders. Under the revised agreement dated December 9, 2025, STAAR stockholders would receive $30.75 per share in cash, equal to a 74% premium to STAAR's 90-day VWAP as of August 4, 2025 and a 66% premium to the August 4 closing price.Analysts cited a ~$1.6bn all-in valuation (~4.5x forward EV/Sales using blended 2026–2027 estimates of $271m and $300m) and noted limited competing bids after the go-shop. ISS updated its report to recommend shareholders vote FOR. A virtual Special Meeting is set for December 19, 2025.

#ALC #STAA Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction

www.stocktitan.net/news/ALC/independent-ind...

Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon {"summary":"","positive":[],"negative":[],"faq":[]}

#ALC #STAA Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon

www.stocktitan.net/news/ALC/broadwood-partn...

STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process {"summary":"","positive":[],"negative":[],"faq":[]}

#ALC #STAA STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process

www.stocktitan.net/news/ALC/staar-surgical-...

Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon {"summary":"","positive":[],"negative":[],"faq":[]}

#ALC #STAA Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon

www.stocktitan.net/news/ALC/broadwood-partn...

Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer {"summary":"","positive":[],"negative":[],"faq":[]}

#ALC #STAA Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer

www.stocktitan.net/news/ALC/yunqi-capital-c...

Broadwood Partners Responds to Alcon’s Increase to Proposed Acquisition Price of STAAR Surgical Broadwood Partners, L.P. and its affiliates today responded to the amended transaction terms of the proposed acquisition of STAAR Surgical Company by Alcon Inc.. Broadwood, which owns 30.2% of STAAR’ s outstanding common stock, continues to oppose the proposed sale of the Company to Alcon and issued the following statement:. “STAAR spent months trying to...

#ALC #STAA Broadwood Partners Responds to Alcon’s Increase to Proposed Acquisition Price of STAAR Surgical

www.stocktitan.net/news/ALC/broadwood-partn...

#ALC #STAA #STAAR Alcon Announces Amended Merger Agreement with STAAR Surgical

www.stocktitan.net/news/ALC/alcon-announces...

Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process {"summary":"","positive":[],"negative":[],"faq":[]}

#ALC #STAA Broadwood Partners Reiterates Opposition to STAAR Surgical’s Sale to Alcon Following Conclusion of Performative Go-Shop Process

www.stocktitan.net/news/ALC/broadwood-partn...

#ALC #STAA STAAR Surgical Announces Expiration of Go-Shop Period

www.stocktitan.net/news/ALC/staar-surgical-...

Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors {"summary":"","positive":[],"negative":[],"faq":[]}

#ALC #STAA Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors

www.stocktitan.net/news/ALC/broadwood-partn...

Yunqi Capital Sells 130,000 Futu Holdings (FUTU) Shares Worth $16.1 Million | The Motley Fool Yunqi Capital Sells 130,000 Futu Holdings (FUTU) Shares Worth $16.1 Million

#FUTU #STAA #LU #QFIN #PDD #API #4798d2e6-a0f9-466b-bc9d-8b7c38640114 #coveragefilings

Origin | Interest | Match

Small-cap stocks with improving money flow, Tue Nov 11th - #STAA #ORMP #ADSE #BCIC #CECO #DSGN #EWTX #GANX #HCAI #INNV #PUBM #NTHI #YEXT #VAN #SFL #NVRI #KOP #FIGS #DV #BAK - More: crystalequityresearch.com/leading-indi... - #smallcap

STAAR Surgical Announces Amendments to Alcon Merger Agreement STAAR Surgical Company, the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses for vision correction, today announced that the Company has agreed with Alcon Inc. to amend their merger agreement to allow proactive solicitation by STAAR of third-party proposals to maximize value for all STAAR stockholders.

#ALC #STAA STAAR Surgical Announces Amendments to Alcon Merger Agreement

www.stocktitan.net/news/ALC/staar-surgical-...

Yunqi Capital Applauds STAAR Surgical’s Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated STAAR Surgical Company 25510 Commercentre Drive Lake Forest, CA 92630. Reported operating expenses were $59.4 million; excluding $5.9 million of merger-related costs with Alcon, the underlying run rate was $53.5 million– annualizing to $214 million and beating prior guidance of $225 million. Separately, the Company's balance sheet strengthened...

#ALC #STAA Yunqi Capital Applauds STAAR Surgical’s Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated

www.stocktitan.net/news/ALC/yunqi-capital-a...

Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects Broadwood Partners, L.P. and its affiliates today commented on the investor presentation issued by Alcon Inc. regarding its proposed acquisition of STAAR Surgical Company. Broadwood, which owns 27.5% of STAAR’ s outstanding common stock, continues to urge its fellow shareholders to vote on its GREEN Proxy Card“ AGAINST” the proposed transaction.

#ALC #STAA Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects

www.stocktitan.net/news/ALC/broadwood-partn...

Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders Alcon, the global leader in eye care, today announced that it has filed an investor presentation in support of the proposed acquisition of STAAR Surgical Company with the U.S. Securities and Exchange Commission. Alcon plans to initiate outreach to STAAR stockholders and the presentation highlights key considerations for these discussions, including:.

#ALC #STAA Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders

www.stocktitan.net/news/ALC/alcon-releases-...

Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon Company (NYSE:ALC) faced public shareholder resistance after Yunqi Capital, a 5.1% shareholder, sent a letter urging STAAR Surgical’s board to terminate the proposed merger announced Aug 5, 2025.Yunqi cited a postponed special meeting now set for December 3, 2025, reported vote results showing roughly 72% of outstanding shares opposed the merger and about 81% opposed a $55 million executive compensation package, and said Alcon provided no commitment to increase consideration as of October 24, 2025.

#ALC #STAA Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon

www.stocktitan.net/news/ALC/yunqi-capital-i...

Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon STAAR Surgical Company 25510 Commercentre Drive Lake Forest, CA 92630. Extending the timeline prolongs uncertainty about STAAR’ s future and delays the Board and management team from implementing a clear strategy to accelerate the Company’ s momentum, particularly in its largest market of China. Continuing a process while Alcon’ s opportunistic $28 per share...

#ALC #STAA Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon

www.stocktitan.net/news/ALC/yunqi-capital-i...